Carboplatin and etoposide chemotherapy in extrapulmonary poorly differentiated neuroendocrine carcinomas

被引：0
|
作者：
Galdy, S. [1 ]
Aurilio, G. [1 ]
Radice, D. [1 ]
Spada, F. [1 ]
Cella, C. A. [1 ]
Frezza, A. M. [1 ]
Nole, F. [1 ]
Fazio, N. [1 ]
机构：
[1] Ist Europeo Oncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
R20
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Nitya Raj
    Jennifer A. Chan
    Stephanie J. Wang
    Rahul R. Aggarwal
    Susan Calabrese
    April DeMore
    Lawrence Fong
    Jennifer Grabowsky
    Thomas A. Hope
    Kanti Pallav Kolli
    Claire K. Mulvey
    Pamela N. Munster
    Kimberly Perez
    Sippy Punn
    Diane Reidy-Lagunes
    Sofia Von Fedak
    Li Zhang
    Emily K. Bergsland
    British Journal of Cancer, 2023, 129 : 291 - 300
  • [2] Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Raj, Nitya
    Chan, Jennifer A.
    Wang, Stephanie J.
    Aggarwal, Rahul R.
    Calabrese, Susan
    DeMore, April
    Fong, Lawrence
    Grabowsky, Jennifer
    Hope, Thomas A.
    Kolli, Kanti Pallav
    Mulvey, Claire K.
    Munster, Pamela N.
    Perez, Kimberly
    Punn, Sippy
    Reidy-Lagunes, Diane
    Von Fedak, Sofia
    Zhang, Li
    Bergsland, Emily K.
    BRITISH JOURNAL OF CANCER, 2023, 129 (02) : 291 - 300
  • [3] First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine
    Andresen, Marie T.
    Knigge, Ulrich
    Hansen, Carsten Palnaes
    Hasselby, Jane Preuss
    Langer, Seppo W.
    CANCER RESEARCH, 2010, 70
  • [4] Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas
    Frizziero, Melissa
    Spada, Francesca
    Lamarca, Angela
    Kordatou, Zoe
    Barriuso, Jorge
    Nuttall, Christina
    McNamara, Mairead G.
    Hubner, Richard A.
    Mansoor, Wasat
    Manoharan, Prakash
    Fazio, Nicola
    Valle, Juan W.
    NEUROENDOCRINOLOGY, 2019, 109 (02) : 100 - 112
  • [5] First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine
    Andresen, Marie T.
    Knigge, Ulrich
    Hansen, Carsten Palnees
    Hasselby, Jane Preuss
    Langer, Seppo W.
    CANCER RESEARCH, 2010, 70
  • [6] The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas
    Smith, James
    Reidy-Lagunes, Diane
    SEMINARS IN ONCOLOGY, 2013, 40 (01) : 100 - 108
  • [7] Paclitaxel, carboplatin, and etoposide (TCE) in advanced poorly differentiated neuroendocrine carcinoma
    Loeffler, Luisa Mantovani
    Mauersberger, Elias
    Weimann, Arved
    Kuerschner, Dorit
    Schimmelpfennig, Christoph
    Wiechmann, Volker
    Bisanz, Heike
    Zeissig, Gisela
    Zeynalova, Samira
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] EXTRAPULMONARY POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMAS (PDNEC) TREATED WITH CISPLATIN PLUS IRINOTECAN
    de Celis Ferrari, Anezka Rubin
    Braghiroli, Maria Ignez
    Bariani, Giovanni Mendonca
    Munhoz, Rodrigo Ranella
    Pfiffer, Tulio Eduardo
    Hoff, Paulo Marcelo
    Riechelmann, Rachel Pimenta
    ANNALS OF ONCOLOGY, 2011, 22 : v80 - v80
  • [9] Efficacy and toxicity of chemotherapy with carboplatin and etoposide in elderly patients with extrapulmonary neuroendocrine carcinoma
    Apostolidis, L.
    Jager, D.
    Winkler, E. C.
    ANNALS OF ONCOLOGY, 2020, 31 : S779 - S779
  • [10] Safety of Irinotecan-based chemotherapy as second-line treatment in extrapulmonary poorly differentiated neuroendocrine carcinomas (NECs)
    Bardasi, C.
    Spallanzani, A.
    Luppi, G.
    Bertolini, F.
    Fontana, A.
    Salati, M.
    Caputo, F.
    Santini, C.
    Cerma, K.
    Dominici, M.
    Gelsomino, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 156 - 156
12345